InspireMD is headquartered in Tel Aviv, Israel
In 2005.
InspireMD is a Delaware Corporation.
InspireMD’s common shares and warrants trade on NASDAQ under the ticker symbols NSPR and NSPR.Z, respectively.
InspireMD’s quarterly financials are released approximately 45 days following the end of the preceding quarter and approximately 90 days following the end of the fiscal year.
InspireMD’s fiscal year ends December 31st.
No, InspireMD does not currently have a direct stock purchase plan.
InspireMD does not currently pay dividends.
Kesselman & Kesselman, Certified Public Accountants, a member of PricewaterhouseCoopers International Limited.
45779A846.
Each year we welcome all of our shareholders to the InspireMD Annual Meeting of Stockholders. Notice of the meeting will be set forth in the annual proxy statement.
Sydny Helbert
Securities Transfer Corporation
2901 N. Dallas Parkway, Suite 380
Plano, Texas 75093
Phone (469) 633-0101
Fax (469) 633-0088
shelbert@stctransfer.com
www.stctransfer.com
Craig Shore
Chief Financial Officer
InspireMD, Inc
Phone: 1-888-776-6804
Email: craigs@inspiremd.com
Or you can reach our investor relations department by emailing investors@inspiremd.com.